abstract |
The present invention provides novel marker genes for the specific identification and characterization of human suppressive and/or regulatory T cells including natural, adaptive, and expanded CD4+ CD25+ FOXP3+ T cells in healthy individuals as well as tumor patients or patients with autoimmune diseases. |